Dishman to make API for Janssen; CPhI award winner finalists announced; Ashland to split;

> Ashland Chemical will divide into two publicly traded companies, one that will manufacture chemicals for pharma and other industries and one that will sell its Valvoline engine products. Release

> India's Dishman Pharmaceuticals and Chemicals said it has been selected by Johnson & Johnson's ($JNJ) Janssen Pharmaceutical to produce the active ingredient for its TB drug Sirturo. Report

> CPhI Worldwide has named the finalists in 7 categories for its annual Pharma Awards, including Catalent ($CTLT), TraceLink, Codexis and others, with winners to be selected Oct. 13 during the annual meeting this year in Madrid. Release

> Nigerian officials have said if they can get an investment of $3 million to $5 million, the country has the capability of producing Coralmyn, the antivenom for coral snake bites that is in short supply. Report

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.